HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gonzalo Pizarro Selected Research

Vasodilator Agents (Vasodilators)

1/2016Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension.
10/2013Noninvasive monitoring of serial changes in pulmonary vascular resistance and acute vasodilator testing using cardiac magnetic resonance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gonzalo Pizarro Research Topics

Disease

16ST Elevation Myocardial Infarction
10/2021 - 10/2012
15Infarction (Infarctions)
10/2021 - 10/2012
12Myocardial Infarction
01/2022 - 10/2012
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 07/2014
4Ischemia
01/2020 - 07/2014
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2021 - 10/2018
3Cardiac Arrhythmias (Arrythmia)
01/2021 - 04/2013
3Reperfusion Injury
01/2020 - 01/2017
3Atrioventricular Block
06/2016 - 10/2012
2Cicatrix (Scar)
10/2021 - 01/2021
2Fibrosis (Cirrhosis)
01/2021 - 01/2014
2Cardiotoxicity
01/2021 - 01/2019
2Ventricular Tachycardia
01/2021 - 01/2014
2Pulmonary Hypertension
01/2016 - 10/2013
2Heart Failure
06/2014 - 06/2008
1Human Influenza (Influenza)
03/2021
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Neoplasms (Cancer)
01/2021
1Hemorrhage
11/2020
1Cardiovascular Diseases (Cardiovascular Disease)
10/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Ventricular Fibrillation
01/2020
1Disease Progression
10/2017
1Coronary Occlusion
05/2017
1Inflammation (Inflammations)
01/2017
1Vascular Remodeling
01/2016
1Ventricular Remodeling
01/2016
1Hypoxia (Hypoxemia)
07/2014
1Left Ventricular Dysfunction
06/2014
1Cardiogenic Shock
10/2013
1Tachycardia (Tachyarrhythmias)
04/2013

Drug/Important Bio-Agent (IBA)

15Metoprolol (Toprol-XL)FDA LinkGeneric
10/2021 - 10/2012
4GadoliniumIBA
10/2021 - 01/2017
3Adrenergic Receptors (Adrenergic Receptor)IBA
01/2018 - 07/2014
2Infliximab (Remicade)FDA Link
05/2021 - 11/2018
2AnthracyclinesIBA
01/2021 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2019
2Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
01/2018 - 01/2016
2Vasodilator Agents (Vasodilators)IBA
01/2016 - 10/2013
1VaccinesIBA
03/2021
1omega-Chloroacetophenone (Mace)IBA
10/2020
1AfatinibIBA
01/2020
1mirabegronIBA
01/2018
1BRL 37344IBA
01/2018
1Glycoproteins (Glycoprotein)IBA
08/2017
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2017
1LipidsIBA
01/2017
1EicosanoidsIBA
01/2017
1Messenger RNA (mRNA)IBA
01/2016
1Biological ProductsIBA
01/2016
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
07/2014
1Mitochondrial Permeability Transition PoreIBA
07/2014
1Cyclophilins (Cyclophilin)IBA
07/2014
1Indicators and Reagents (Reagents)IBA
01/2014
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2013
1Bronchodilator Agents (Bronchodilators)IBA
10/2012
1Pharmaceutical PreparationsIBA
10/2012

Therapy/Procedure

10Percutaneous Coronary Intervention
01/2021 - 10/2012
7Therapeutics
01/2022 - 06/2008
2Catheter Ablation
01/2021 - 04/2013
1Drug Therapy (Chemotherapy)
01/2020
1Immunotherapy
01/2020
1Complementary Therapies (Alternative Medicine)
10/2018
1Intravenous Administration
01/2018